Prophylactic treatment of bleeding episodes in children < 12  years with moderate to severe hereditary factor X deficiency (FXD): Efficacy and safety of a high‐purity plasma‐derived factor X (pdFX) concentrate

Haemophilia, EarlyView.

Source: Haemophilia - April 30, 2018 Category: Hematology Authors: R. Liesner , C. Akanezi , M. Norton , J. Payne Source Type: research